Login

Financial Snapshot

Revenue
TTM
$212.1M
Gross Margin
TTM
-46.45%
Net Income
TTM
-$143.3M
Current Assets
2022 Q3
Current Liabilities
2022 Q3
Current Ratio
2022 Q3
145.99%
Total Assets
2022 Q3
Total Liabilities
2022 Q3
Book Value
2022 Q3
60.89M
Cash
2022 Q3
P/E
Last 4 Quarters
N/A
Free Cash Flow
TTM
-$72.60M

Stock Price

Loading...
Market Cap: $8.12 Thousand

About Lucira Health, Inc.

Lucira Health, Inc. is a medical technology company, which engages in the business of developing and commercializing transformative and innovative infectious disease test kits. The company is headquartered in Emeryville, California and currently employs 221 full-time employees. The company went IPO on 2021-02-05. The firm has no business operations and is in liquidation.

Industry: In Vitro & In Vivo Diagnostic Substances Peers: Abbott Laboratories Aspira Women's Health Inc Modular Medical Inc Biomerica Inc Cytosorbents Corp Eargo, Inc. Kewaunee Scientific Corp Milestone Scientific Inc

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support